BR0302470A - Composições antiácidas lìquidas - Google Patents

Composições antiácidas lìquidas

Info

Publication number
BR0302470A
BR0302470A BR0302470-9A BR0302470A BR0302470A BR 0302470 A BR0302470 A BR 0302470A BR 0302470 A BR0302470 A BR 0302470A BR 0302470 A BR0302470 A BR 0302470A
Authority
BR
Brazil
Prior art keywords
amount
containing compounds
liquid antacid
propylene glycol
group
Prior art date
Application number
BR0302470-9A
Other languages
English (en)
Inventor
Donald L Hasenmayer
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of BR0302470A publication Critical patent/BR0302470A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçõES ANTIáCIDAS LìQUIDAS". A invenção refere-se às preparações antiácidas líquidas compreendendo: a) um composto de neutralização de ácido ativo selecionado do grupo consistindo em compostos contendo cálcio, compostos contendo alumínio, compostos contendo magnésio, e misturas destes; e b) um adjuvante antimicrobinao selecionado a partir do grupo consistindo em propileno glicol em uma quantidade maior do que 2% em peso e menor do que 15% em peso, glicerina em uma quantidade de cerca de 15 a cerca de 20% em peso, e combinações de propileno glicol em uma quantidade de cerca de 3 a cerca de 10% em peso com glicerina em uma quantidade de cerca de 3 a cerca de 10% em peso com base no peso total da preparação, são fornecidas.
BR0302470-9A 2002-06-14 2003-06-16 Composições antiácidas lìquidas BR0302470A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/171,707 US20030232092A1 (en) 2002-06-14 2002-06-14 Liquid antacid compositions

Publications (1)

Publication Number Publication Date
BR0302470A true BR0302470A (pt) 2004-08-24

Family

ID=29717770

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0302470-9A BR0302470A (pt) 2002-06-14 2003-06-16 Composições antiácidas lìquidas

Country Status (20)

Country Link
US (1) US20030232092A1 (pt)
EP (1) EP1374874B1 (pt)
JP (1) JP2004035551A (pt)
KR (1) KR20030096085A (pt)
CN (1) CN1470246A (pt)
AR (1) AR039693A1 (pt)
AT (1) ATE340582T1 (pt)
AU (1) AU2003204688B2 (pt)
BR (1) BR0302470A (pt)
CA (1) CA2432231A1 (pt)
DE (1) DE60308595T2 (pt)
ES (1) ES2271483T3 (pt)
HU (1) HUP0301715A2 (pt)
MX (1) MXPA03005343A (pt)
NZ (1) NZ526459A (pt)
PL (1) PL360680A1 (pt)
PT (1) PT1374874E (pt)
RU (1) RU2322246C2 (pt)
SA (1) SA03240232B1 (pt)
ZA (1) ZA200304650B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080260823A1 (en) * 2007-04-20 2008-10-23 Sciele Pharma, Inc. Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
RU2635276C1 (ru) 2016-06-24 2017-11-09 Акционерное общество "Лаборатория Касперского" Безопасная аутентификация по логину и паролю в сети Интернет с использованием дополнительной двухфакторной аутентификации
CN108721213A (zh) * 2017-04-13 2018-11-02 辽宁大熊制药有限公司 铝镁混悬液及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL32020A (en) * 1968-04-18 1972-11-28 Brown G Antacid compositions
JPH0692309B2 (ja) * 1986-11-22 1994-11-16 富士化学工業株式会社 懸濁制酸剤
AU3328193A (en) * 1991-12-17 1993-07-19 Fuisz Technologies Ltd. Ulcer prevention and treatment composition and method
EP0700283B1 (en) * 1993-05-26 1998-11-25 The Procter & Gamble Company Liquid antacid compositions
DE19529862A1 (de) * 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
JP3615894B2 (ja) * 1997-01-20 2005-02-02 株式会社ノエビア 抗菌性低刺激化粧料

Also Published As

Publication number Publication date
AR039693A1 (es) 2005-03-09
RU2322246C2 (ru) 2008-04-20
ATE340582T1 (de) 2006-10-15
EP1374874A2 (en) 2004-01-02
DE60308595T2 (de) 2007-08-09
HU0301715D0 (en) 2003-08-28
US20030232092A1 (en) 2003-12-18
EP1374874B1 (en) 2006-09-27
ZA200304650B (en) 2005-01-24
SA03240232B1 (ar) 2007-07-31
KR20030096085A (ko) 2003-12-24
NZ526459A (en) 2004-11-26
AU2003204688A1 (en) 2004-01-15
EP1374874A3 (en) 2004-01-07
DE60308595D1 (de) 2006-11-09
HUP0301715A2 (hu) 2005-07-28
PT1374874E (pt) 2006-12-29
MXPA03005343A (es) 2004-10-29
CN1470246A (zh) 2004-01-28
ES2271483T3 (es) 2007-04-16
PL360680A1 (en) 2003-12-15
CA2432231A1 (en) 2003-12-14
AU2003204688B2 (en) 2008-04-10
JP2004035551A (ja) 2004-02-05

Similar Documents

Publication Publication Date Title
RU2005121556A (ru) Высокоэффективные соли алюминия с низким раздражающим эффектом и антиперспирантные продукты
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
BR0316532A (pt) Composições farmacêuticas compreendendo, um composto de droga básico, respectivamente um ácido, um tensoativo e um ácido solúvel em água fisiologicamente tolerável, respectivamente, uma base
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
CO5570649A2 (es) Producto antitranspirante en gel liquido de alta eficiencia
BRPI0409185A (pt) formulações veterinárias anti-helmìnticas tópicas
NO20051102L (no) Sulfonylamino-eddiksyre-derivater
ES2091441T3 (es) Composicion farmaceutica.
BRPI0511036A (pt) formulações de solução farmacêuticas contendo 17-aag
RU97107927A (ru) Композиция на основе водных растворов хитозана, повышающие устойчивость растений к болезням
BRPI0410219A (pt) composições farmacêuticas de vareniclina
EA201200185A1 (ru) Фармацевтическая композиция для пероральной доставки дииндолилметана
BR0309057A (pt) Formulações lìquidas com baixa dosagem em entecavir e uso
PE20030201A1 (es) Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion
ECSP045110A (es) Composiciones de la preparación que contiene un compuesto fisiologicamente activo de acidos inestables y procesos para su producción
CO4930324A1 (es) Composicion quimica que contiene un sistema preservativo y metodo para elaborar y usar tal composicion
BR0302470A (pt) Composições antiácidas lìquidas
HUP0300018A2 (hu) Kis ragadóssággal rendelkező rúd alakú kozmetikai készítmény
BR0109139B1 (pt) composiÇÕes farmacÊuticas incluindo alginatos
TR200002441T2 (tr) İnsanlar üzerindeki parazit böcekleri ve kurtçukları kontrol etmek için su içeren bileşimler.
BRPI0412453A (pt) uso do ácido ascórbico ou um sal fisiologicamente aceitável do mesmo
AR008764A1 (es) Sales hidratadas de n,n'-diacetilcistina, proceso para su preparacion, y composiciones terapeuticas que comprenden a dichas sales como ingredienteactivo.
BR0215498A (pt) Composição farmacêutica compreendendo uma glitazona e um ácido 4-oxobutanóico e o seu uso para o tratamento de diabetes
RU2000113775A (ru) Препарат для профилактики и лечения эндометрита
BR0303489A (pt) Composição farmacêutica estabilizada de composto flúor-éter e método para inibir a degradação de composto flúor-éter. uso de agente estabilizante para inibir a degradação de composto flúor éter

Legal Events

Date Code Title Description
B03H Publication of an application: rectification [chapter 3.8 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2156 DE 02/05/2012.